Abstract

A metabolomics approach for prediction of bacteremic sepsis in patients in the emergency room (ER) was investigated. In a prospective study, whole blood samples from 65 patients with bacteremic sepsis and 49 ER controls were compared. The blood samples were analyzed using gas chromatography coupled to time-of-flight mass spectrometry. Multivariate and logistic regression modeling using metabolites identified by chromatography or using conventional laboratory parameters and clinical scores of infection were employed. A predictive model of bacteremic sepsis with 107 metabolites was developed and validated. The number of metabolites was reduced stepwise until identifying a set of 6 predictive metabolites. A 6-metabolite predictive logistic regression model showed a sensitivity of 0.91(95% CI 0.69–0.99) and a specificity 0.84 (95% CI 0.58–0.94) with an AUC of 0.93 (95% CI 0.89–1.01). Myristic acid was the single most predictive metabolite, with a sensitivity of 1.00 (95% CI 0.85–1.00) and specificity of 0.95 (95% CI 0.74–0.99), and performed better than various combinations of conventional laboratory and clinical parameters. We found that a metabolomics approach for analysis of acute blood samples was useful for identification of patients with bacteremic sepsis. Metabolomics should be further evaluated as a new tool for infection diagnostics.

Highlights

  • The World Economic Forum has identified antibiotic resistance as one of the greatest risks of human health [1]

  • Our study suggests that biomarkers identified by metabolomic analysis of blood taken in the emergency room (ER) can be used for differentiation between patients with and without bacteremic sepsis

  • 97.6 1.000 0.947 0.958 1.000 0.977 a Model performances were calculated with Fischer’s exact test using 2x2 tables of predicted probabilities obtained via logistic regression

Read more

Summary

Introduction

The World Economic Forum has identified antibiotic resistance as one of the greatest risks of human health [1]. As antibiotic resistance is emerging, antibiotic choices that were considered to be reliable a decade ago for treating bacteremic sepsis may be uncertain treatment options today. The number of excess deaths among patients with bacteremia in Europe, attributable to antibiotic resistance exceeded 8,000 in year 2007 for Staphylococcus aureus and Escherichia coli infections, and trajectories for 2015 suggest 17,000 fatalities [2]. Reduction of unnecessary antibiotic use has been identified as one of the most important issues in order to stop the emergence of antibiotic resistance [3]. There is an urgent need for diagnostic tools that can support.

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.